SERVIER PARTNERS WITH BIOLABS TO OPEN AN INCUBATOR IN PARIS-SACLAY FOR EARLY STAGE LIFE SCIENCE START-UPS
14/10/2021
Our News
21900
employees
150
countries in which
the Group’s
medicines are
distributed
+20％
Over 20% of
revenue from
brand- name medicines
invested in R&D each year
€5.3 billion euros
in revenue in 2022/2023 including
€4 billion for brand- name medicines and €1.3 billion for generic activities
4 therapeutic areas
Oncology, Neuroscience, Immuno-inflammation, Cardiometabolism
Servier Medical Art is a medical image bank that we make available to illustrate your medical releases.
OUR COMMITMENTS
Above all, we believe in our profession!
We are a research-based organisation. We are focused on the future and on useful discoveries.
All our activities are based on three key principles.